Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Blood|February 11, 2005
The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cellsYuval Shaked, Dave Cervi, Manuela Neuman, et al.
Heliyon|July 24, 2023
Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammationMatthew A Churchward, Emily R Michaud, Benjamin H Mullish, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 8, 2018
Association between α<sub>1</sub>-antitrypsin and bronchiectasis in patients with humoral immunodeficiency receiving gammaglobulin infusionsBrian P Peppers, Jamie Zacharias, Chelsea R Michaud, et al.
Veterinary Pathology|July 8, 2011
Spontaneous pulmonary alveolar proteinosis in captive "moustached tamarins" (Saguinus mystax)C R Michaud, D R Ragland, K I Shea, et al.
Journal of Dairy Science|October 4, 2008
Alfalfa cut at sundown and harvested as baleage improves milk yield of late-lactation dairy cowsA F Brito, G F Tremblay, A Bertrand, et al.
Journal of Dairy Science|January 29, 2010
Effects of nonstructural carbohydrate concentration in alfalfa on fermentation and microbial protein synthesis in continuous cultureR Berthiaume, C Benchaar, A V Chaves, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PETJeffrey R Tseng, Keon Wook Kang, Mangal Dandekar, et al.
Mucosal Immunology|May 2, 2013
Lung epithelial cells are essential effectors of inducible resistance to pneumoniaJ O Cleaver, D You, D R Michaud, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2021
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cuesTony Yao, Patrick T Rudak, Céline M Laumont, et al.
The Lancet. Oncology|May 19, 2022
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 studyMarjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, et al.
Pageof 5